WALTHAM, Mass.--(BUSINESS WIRE)--$NURO #NeuroMetrix--NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Quell® is now available at Brookstone.com. "Brookstone is known for selling leading edge technology," said Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix. "We are pleased to be working with Brookstone to broaden the availability of our Quell proprietary, 100% drug free technology for the relief of widespread chronic pain.” Quell is FDA cleared and designed for millions of people suffering from c
![]()
↧